Perimenopause and ADHD: When Your Brain Feels Like It’s Betraying You
Estrogen modulates dopamine. When it drops in perimenopause, it can expose lifelong ADHD that driven women spent decades compensating for. This post explores the neurobiology behind this unmasking, why so many women aren’t diagnosed until midlife, and what integrated treatment — combining hormonal support, medication, and therapy — actually looks like in practice.
- The Folder That Changed Everything
- What Is ADHD in Women?
- The Neurobiology of Perimenopause and ADHD
- How the ADHD Reveal Shows Up in Driven Women
- The Trauma and ADHD Overlap: Hypervigilance and Hyperfocus
- Both/And: It’s ADHD and Perimenopause — Treating One Without the Other Fails
- The Systemic Lens: Why Women Go Undiagnosed for Decades
- The Integrated Path Forward: Stimulants, HRT, and Therapy
- Frequently Asked Questions
The Folder That Changed Everything
It’s 9:12 p.m. in a San Francisco high-rise. Aarti, a venture capital partner in her early 40s, sits alone at her kitchen island, the city lights spreading out behind her in a glittering grid she barely registers. In her hands is a thick manila folder — her twelve-year-old daughter’s ADHD evaluation, just completed after months of waiting for an appointment. The pediatric neuropsychologist’s report is dense, clinical, thorough.
Aarti starts reading, and something happens she wasn’t expecting: recognition. Not of her daughter. Of herself. The inattentiveness, the overwhelm, the relentless inner chatter that she’d always chalked up to ambition or anxiety. The chronic feeling of falling behind despite working twice as hard as everyone around her. The way she’d built elaborate compensatory systems — color-coded calendars, voice memos, assistants who managed her managers — not because she was organized but because without those scaffolds, she’d fall apart.
By page four of the report, Aarti’s hands are shaking slightly. She’s been in perimenopause for about eighteen months. The brain fog that started last year, the sudden inability to hold a complex thought long enough to execute it, the meetings where she lost the thread mid-sentence — she’d been calling this perimenopause. But looking at her daughter’s diagnosis, she wonders if perimenopause has just stripped away the scaffolding that was hiding something that’s been there her entire life.
In my work with driven women navigating midlife, Aarti’s story — the late-night recognition, the cascade of retroactive understanding — is one of the most common clinical presentations I encounter. Perimenopause doesn’t create ADHD. But for women who’ve spent decades compensating for undiagnosed ADHD with estrogen’s neurochemical support, the hormonal shifts of this transition can remove the scaffolding entirely. What’s revealed isn’t new. It’s just finally visible. And the intersection of perimenopause and brain function is one of the most underexplored areas in women’s mental health.
What Is ADHD in Women?
Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental condition characterized by persistent patterns of inattention, hyperactivity, and impulsivity that significantly interfere with daily functioning. In women, ADHD frequently presents with a predominantly inattentive subtype — without the overt hyperactivity more visible in boys — leading to widespread underdiagnosis and late diagnosis. Lotta Borg Skoglund, MD, PhD, psychiatrist and neuroscientist at Uppsala University and a leading researcher on ADHD and hormonal influences in women, has demonstrated that estrogen actively modulates the dopaminergic pathways that underlie ADHD symptoms, meaning that female ADHD presentations are inherently hormonally sensitive in ways male-based diagnostic criteria have historically failed to capture.
In plain terms: ADHD in women often looks nothing like the hyperactive boy in the classroom. Instead, it shows up as chronic overwhelm, scattered thinking, and mental exhaustion — symptoms that look like anxiety or burnout until the estrogen support that was masking them disappears. For many driven women, the diagnosis arrives in their 40s, triggered by the very thing that removes their biological compensation: perimenopause.
In my clinical work, what I see repeatedly is that driven women have spent decades building mental scaffolding that estrogen helped maintain — until it fluctuates and falls. The inattentive presentation of ADHD in women is subtle and often invisible to the outside world. It’s the missed appointments quietly rescheduled before anyone notices. The midnight catch-up sessions that made up for the afternoon where nothing got done. The relentless internal effort to appear organized when the interior experience is anything but.
For many women, a first ADHD diagnosis lands in their 30s, 40s, or even 50s, often triggered by life changes that strip away the compensatory strategies they’d been relying on. A child’s diagnosis — like Aarti’s daughter — can be the mirror. So can a job loss, a divorce, or a perimenopause transition that alters the very neurochemical environment that was holding the compensation in place.
Late diagnosis is not merely a clinical inconvenience. It’s a profound identity disruption. Women often feel like they’ve been failing themselves — and others — for years, without a framework that explained why. The ADHD reveal in midlife is both a relief and a reckoning. It changes the story, but it also demands grieving the years spent navigating a neurological difference without any support or name for what you were dealing with.
The Neurobiology of Perimenopause and ADHD
Estrogen, a primary female sex hormone, modulates dopamine pathways in the brain — particularly within the prefrontal cortex, which governs executive functions including attention, working memory, and self-regulation. Lotta Borg Skoglund, MD, PhD, psychiatrist and neuroscientist at Uppsala University, has demonstrated through neuroendocrine research that estrogen enhances dopaminergic receptor sensitivity, stabilizing attention and cognitive control in ways that partially compensate for ADHD-related deficits. As estrogen levels fluctuate and decline during perimenopause, dopamine signaling becomes dysregulated, amplifying underlying ADHD symptoms that may have been partially managed for years by the buffering effect of stable estrogen.
In plain terms: Estrogen acts like a natural “attention stabilizer” by helping your brain’s dopamine system function smoothly. When estrogen drops during perimenopause, the brain’s ability to focus, plan, and organize takes a hit — especially if you have ADHD. This isn’t a new problem emerging in midlife; it’s an existing neurological difference that your hormones were quietly compensating for, now exposed.
The dopamine-estrogen relationship is the key to understanding why so many driven women suddenly experience a dramatic cognitive shift in their 40s. Dopamine is central to the brain’s executive control network — managing task prioritization, impulse control, and sustained attention. Estrogen’s enhancement of dopamine receptor sensitivity in the prefrontal cortex means that when estrogen fluctuates or declines, the dopaminergic system loses a significant regulatory support it had been relying on. This isn’t ADHD appearing out of nowhere; it’s the unveiling of a lifelong neurodevelopmental difference that was previously partially compensated for by stable estrogen levels.
Pauline Maki, PhD, professor of psychiatry and psychology at the University of Illinois Chicago and one of the leading researchers on perimenopausal cognitive changes, notes that perimenopausal women with ADHD often report marked declines in working memory, processing speed, and mental clarity that parallel their hormonal shifts. These cognitive symptoms are frequently misattributed to “menopausal brain fog” when they’re actually the neurobiological consequence of estrogen withdrawal acting on an ADHD brain. Understanding this distinction matters enormously for treatment — because treating the hormonal piece alone without addressing the ADHD, or addressing the ADHD without stabilizing the hormonal environment, typically produces incomplete results.
There’s also a feedback loop worth understanding. Unmanaged ADHD symptoms increase stress and cortisol levels, which in turn further impair prefrontal cortex function. This cycle deepens the executive dysfunction and emotional dysregulation experienced during perimenopause, particularly in women carrying heavy professional and caregiving loads. The anxiety and sleep disruption that often accompany perimenopause can make ADHD symptoms dramatically worse — and vice versa. Untangling these overlapping systems is complex clinical work, and it’s why integrated care matters.
How the ADHD Reveal Shows Up in Driven Women
Rachel is a 43-year-old law partner at a prestigious New York firm. For two decades, she’s been known for her razor-sharp organizational skills, her encyclopedic case memory, her ability to juggle twenty things without dropping any of them. But over the past eighteen months, something has shifted. She arrives late to depositions — a first. She forgets critical client details that she would have retained effortlessly before. Her once-legendary focus feels like it’s operating through gauze: present but imprecise, there but unreliable.
Her psychiatrist, after several months of exploring anxiety and depression diagnoses and finding incomplete improvement, finally recommends a comprehensive adult ADHD evaluation. The results are unambiguous: Rachel has inattentive ADHD, masked for decades behind her perfectionism, hypervigilance, and the estrogen that had been buffering her dopamine system. The perimenopause transition removed that buffer. What had always been there became undeniable.
The diagnosis brings what I’ve heard described as a “cruel gift” — a profound validation of struggles that had always felt inexplicable alongside a grief for the years spent compensating without support. Rachel tells me in one of our sessions: “I used to think I was just bad at being a person. I worked twice as hard as everyone else to look like I was keeping up. Now I find out I actually was working twice as hard — because my brain needed me to.”
In clinical practice, I see variations of Rachel’s story consistently. The women who become most skilled at compensation are often the ones most difficult to diagnose — their external performance doesn’t reflect the internal effort required to maintain it. Perimenopause removes the estrogen buffer, increases the cognitive load, and makes compensation impossible to sustain. The system collapses. And what’s revealed isn’t failure; it’s a neurobiological reality that was always there, finally demanding to be named and treated.
What also emerges in these moments is the exhaustion of decades of not knowing. The shame that accumulated around struggles that felt inexplicable. The relationships strained by forgetfulness that was never carelessness. The careers marked by patterns that made no sense to anyone — including the woman living them. Getting an ADHD diagnosis in midlife doesn’t erase any of that, but it does provide a framework for finally making sense of it — and for getting the right support. If this resonates, taking Annie’s free quiz can be a useful first step toward understanding the deeper patterns shaping your experience.
The Trauma and ADHD Overlap: Hypervigilance and Hyperfocus
It’s late evening in Imani’s home office. The room is quiet — her teenagers are asleep, the house finally still. She’s a 46-year-old executive director at a major nonprofit, and she’s been trying to work on a grant report for three hours. The document is open. The deadline is tomorrow. But she can’t quite land on it — her mind keeps skating away, landing on a conversation from this morning, a worried email, a question she forgot to answer. And then, suddenly, an article she finds links to another and another, and two hours disappear into a rabbit hole she can’t fully account for.
Imani has been in therapy for three years for what was originally framed as anxiety and complex PTSD from a difficult childhood. She’s made significant progress. But the cognitive piece — the inability to reliably begin and sustain tasks, the hyperalertness to emotional cues in meetings, the way her attention works intensely when she’s in crisis and barely at all when she’s not — has never quite resolved. What we’re discovering together is that she’s likely been navigating both undiagnosed ADHD and trauma-driven hypervigilance simultaneously, each masking and compounding the other.
Hypervigilance is a state of heightened sensory sensitivity and exaggerated environmental scanning for threat, associated with trauma exposure and dysregulation of the autonomic nervous system. Bessel van der Kolk, MD, psychiatrist and trauma researcher at Boston University and author of The Body Keeps the Score, describes hypervigilance as a persistent, automatic state of alertness that consumes significant cognitive resources — leaving less capacity available for the kind of sustained, regulated attention that complex tasks require.
In plain terms: If you’ve experienced relational trauma, your nervous system learned to stay on high alert — scanning constantly for danger. This looks like anxiety, but it also consumes the very cognitive resources you need for focus, planning, and follow-through. It can be nearly impossible to distinguish from ADHD without careful clinical assessment.
Women with histories of relational trauma frequently develop hypervigilance as a protective adaptation. In contrast, hyperfocus — commonly seen in ADHD — is an intense, sometimes consuming concentration on a task or interest, often to the exclusion of everything else. The paradox is that hypervigilance and hyperfocus can coexist in the same woman: simultaneously primed for threat detection and prone to losing hours in something that captured her attention completely.
Hyperfocus is a phenomenon associated with ADHD characterized by prolonged, intense concentration on a task or area of interest — often to the point of losing awareness of time, surroundings, and competing obligations. Lotta Borg Skoglund, MD, PhD, explains hyperfocus as both a coping mechanism and a manifestation of the dysregulated executive attention system: attention that cannot be reliably modulated, swinging between unavailability and intense absorption rather than operating with flexible, intentional regulation.
In plain terms: You can get so completely absorbed in something interesting that you lose track of time, forget to eat, miss appointments — while simultaneously struggling to begin or sustain attention on tasks that feel less engaging. This isn’t laziness or poor time management. It’s a feature of how the ADHD brain regulates attention.
The clinical challenge is that hypervigilance and hyperfocus produce overlapping presentations that standard ADHD assessments weren’t designed to untangle. A woman who appears highly attentive and responsive in her environment (because her trauma keeps her scanning constantly) may not appear inattentive in a clinical interview — even when she struggles profoundly with executive function in real-world contexts. This is one reason why trauma history must be assessed alongside ADHD evaluation in midlife women. The reactivation of trauma patterns during perimenopause is common, and understanding the overlap between trauma and ADHD is essential for accurate diagnosis and effective treatment.
In my work with women like Imani, untangling these two systems requires patience, careful observation, and a therapeutic approach that honors both the trauma history and the neurodevelopmental reality. They’re not the same thing. They’re not mutually exclusive. And treating one without addressing the other consistently produces incomplete results. Trauma-informed therapy that understands ADHD is one of the most effective interventions available for women in this particular intersection.
Both/And: It’s ADHD and Perimenopause — Treating One Without the Other Fails
Aarti — who opened this post reading her daughter’s evaluation at 9 p.m. in her San Francisco kitchen — eventually does get evaluated herself. The results confirm inattentive ADHD. She’s 42 years old and has never had a name for the experience she’s been managing since childhood.
Her psychiatrist initially focuses on HRT to stabilize the hormonal environment, reasoning that once her estrogen levels are more consistent, the cognitive symptoms should improve. And they do, partially. The worst of the brain fog lifts. But the core executive function struggles — the task initiation difficulties, the working memory deficits, the time blindness — remain. Because they’re not new. They predate perimenopause by three decades. They were just more manageable when her estrogen was stable.
This is the Both/And reality I witness repeatedly: perimenopause and ADHD aren’t competing diagnoses. They’re intersecting realities that demand integrated treatment. Treating one without the other is like patching half a roof and wondering why rain still gets in.
“Tell me, what is it you plan to do / with your one wild and precious life?”
Mary Oliver, poet, “The Summer Day”
Lotta Borg Skoglund, MD, PhD, has articulated this with particular clarity: estrogen fluctuations worsen ADHD symptoms by disrupting the very dopaminergic stabilization that was holding them in check. Simultaneously, the psychosocial demands on driven women in this age group — professional pressures, caregiving responsibilities, unresolved relational trauma — intensify the overall cognitive load. The result is a perfect storm where untreated ADHD is unmasked by hormonal shifts, yet misattributed entirely to perimenopause or burnout.
Pauline Maki, PhD, professor of psychiatry and psychology at the University of Illinois Chicago, has emphasized in her work on perimenopausal cognition that women receive incomplete care when clinicians focus exclusively on hormonal symptoms without evaluating for underlying neurodevelopmental differences. The reverse is equally true: treating ADHD pharmacologically while ignoring the hormonal environment that’s amplifying symptoms often results in needing higher medication doses than necessary, more side effects, and less stable improvement.
What works — and what I’ve seen work in practice — is integrated care that addresses both the hormonal and the neurodevelopmental dimensions simultaneously, with psychotherapy providing the relational and identity processing that neither HRT nor stimulant medication can do. For many women, receiving this kind of integrated support in midlife is genuinely transformative — not just symptom management, but a fundamental shift in how they understand themselves and what they need. If you’re wondering whether this might be your picture, a free consultation is a good place to start.
The Systemic Lens: Why Women Go Undiagnosed for Decades
Why do so many driven women endure four decades or more before receiving an ADHD diagnosis? The answer isn’t individual failure. It’s embedded in systemic and structural failures that have historically made female ADHD invisible.
ADHD diagnostic criteria were developed primarily from research on school-aged boys exhibiting hyperactive-impulsive symptoms. The inattentive presentation — which predominates in women, particularly those who are driven and academically successful — was largely invisible in the early research. This gender bias in clinical criteria means that the very women most likely to have ADHD are the least likely to fit the stereotyped presentation that triggers referral for evaluation.
The cultural myth that ADHD is incompatible with professional success functions as a form of systemic gaslighting for driven women. “You can’t have ADHD — you’re too successful” is something many women I work with have been told explicitly by well-meaning clinicians. What this ignores is that successful women with ADHD are often successful specifically because of the enormous compensatory effort they’ve been exerting — effort that’s exhausting, unsustainable, and invisible to everyone except themselves.
Healthcare providers frequently lack training in adult female ADHD and its intersectionality with trauma, perimenopause, and neuroendocrine changes. This gap produces a cascade of misdiagnosis — anxiety, depression, burnout, personality disorder — that delays appropriate treatment by years or decades. Women in their 40s navigating perimenopausal cognitive symptoms are often told “this is just menopause” by providers who aren’t looking for the neurodevelopmental layer underneath.
Systemic pressures extend beyond clinical settings. Women in midlife — particularly those in the sandwich generation caring simultaneously for children and aging parents — are operating under cognitive loads that would challenge any nervous system. That context makes it nearly impossible to distinguish “I’m overwhelmed by my circumstances” from “I’m overwhelmed by my circumstances and I have an undiagnosed neurodevelopmental difference that makes this significantly harder than it needs to be.” The identity disruption of perimenopause alone is significant — add an ADHD diagnosis on top of it, and the need for skilled, comprehensive support becomes urgent.
Recognizing these systemic dynamics isn’t just intellectually interesting. It’s clinically necessary for validating women’s experiences, reducing shame, and building toward diagnostic and treatment models that actually account for how ADHD presents in driven women across the lifespan.
The Integrated Path Forward: Stimulants, HRT, and Therapy
When driven women come to me navigating the perimenopause-ADHD intersection, our first priority is accurate assessment. Diagnosing adult ADHD in women requires clinical expertise and often benefits from collaboration between psychiatry, endocrinology, and psychotherapy. The evaluation needs to include a detailed developmental history, screening for trauma exposure, assessment of perimenopausal symptoms, and differential diagnosis that considers the full clinical picture — not just the presenting complaints.
Once ADHD is confirmed, treatment can proceed on multiple fronts simultaneously.
Pharmacotherapy: Stimulant medications remain the gold standard for adult ADHD. Medications that improve dopamine and norepinephrine signaling in the prefrontal cortex — lisdexamfetamine, methylphenidate, and their variants — can dramatically improve attention and executive function. For perimenopausal women, the interaction between stimulants and hormonal fluctuations deserves careful monitoring, as the same estrogen variability that unmasked ADHD can affect medication response across the menstrual cycle and transition.
Hormone replacement therapy: HRT can stabilize the estrogen environment, mitigating the dopamine dysregulation that amplifies ADHD symptoms. Lotta Borg Skoglund, MD, PhD, has documented how estrogen stabilization during perimenopause can meaningfully improve cognitive performance and attention in women with ADHD — often allowing stimulant medication to work more effectively at lower doses. The combination of HRT and ADHD pharmacotherapy, when medically appropriate and coordinated, can produce significantly better outcomes than either alone. The HRT decision from a therapist’s perspective explores this in more depth.
Therapy: Cognitive-behavioral therapy adapted for adult ADHD can build organizational strategies, executive function scaffolding, and emotional regulation skills. But from a trauma-informed, relational lens — which is where my work lives — the deeper work involves addressing the shame accumulated around decades of undiagnosed struggle, the relational wounds that came from being misunderstood, and the identity reconstruction that a late diagnosis demands. Working one-on-one with a therapist who understands both perimenopause and ADHD can provide the comprehensive support this transition requires. The Fixing the Foundations course is another resource specifically designed for driven women rebuilding their psychological foundations — and many of the women I work with find it a valuable complement to individual therapy.
Psychoeducation and community: Understanding the neurobiological reality of the estrogen-dopamine relationship gives women a framework for making sense of their experience rather than pathologizing themselves. Staying connected to accurate, clinically-grounded information — through resources like the Strong & Stable newsletter — can make a meaningful difference in how women move through this transition.
Aarti, Imani, and Rachel — the women whose stories open and weave through this post — are composite portraits of women I’ve sat with in practice. Their experiences are distinct, but the common thread is consistent: the perimenopause-ADHD reveal, when properly understood and properly treated, isn’t a sentence. It’s an explanation. And finally having an explanation, after decades of effortful compensation without one, can be the beginning of a genuinely different relationship with yourself and your capacities.
You haven’t been failing. You’ve been navigating a neurobiological reality without a roadmap. Now there’s one. Take the first step toward finding the right support by connecting with Annie’s team.
PERIMENOPAUSE LIBRARY
This is one piece of a larger conversation. Browse Annie’s complete perimenopause library — 42 articles organized by symptom, identity, relationships, profession, and treatment.
Q: Is it really ADHD or just perimenopause?
A: It can be both — and that’s exactly why accurate assessment matters. Perimenopause brings significant hormonal fluctuations, especially in estrogen, which modulates the dopamine pathways critical for attention and executive function. When estrogen drops, it can unmask lifelong ADHD that was previously compensated for by stable estrogen levels and decades of built-up coping strategies. Lotta Borg Skoglund, MD, PhD, psychiatrist and neuroscientist at Uppsala University, has documented how estrogen fluctuations directly worsen ADHD symptomatology in perimenopausal women. If you’re experiencing new or dramatically worsened difficulties with focus, organization, or task initiation during perimenopause, a thorough evaluation that considers both hormonal changes and the possibility of underlying ADHD is essential. Simply attributing everything to perimenopause risks missing a treatable neurodevelopmental condition.
Q: Can stimulant medications and HRT be taken together?
A: Yes, in many cases they can — and often should be — used in an integrated treatment approach. Stimulant medications target dopamine and norepinephrine pathways to improve ADHD symptoms; HRT stabilizes estrogen levels that modulate those same neurotransmitter systems. The two interventions work on complementary mechanisms. That said, this combination requires careful medical coordination by clinicians familiar with both perimenopausal neuroendocrinology and ADHD pharmacology. The goal is synergy: HRT alone rarely resolves core ADHD symptoms, and stimulants alone may be less effective or require higher doses when the hormonal environment is unstable.
Q: I’m very successful professionally. Can I really have ADHD?
A: Yes. This is one of the most persistent and damaging myths about ADHD in women. Professional success doesn’t exclude ADHD — it often coexists with it, because driven women with ADHD frequently build elaborate compensatory systems that maintain external performance at enormous internal cost. The exhaustion, the sense of working twice as hard as everyone around you, the private chaos beneath the polished surface — these are often ADHD signatures in high-performing women. The “you can’t have ADHD if you’re this accomplished” narrative is a cultural barrier that delays diagnosis and treatment for years. If you suspect ADHD, your accomplishments don’t negate your symptoms. They amplify the need for accurate evaluation.
Q: Will HRT fix my ADHD symptoms?
A: HRT can be an important part of the picture but rarely a complete solution for ADHD. Estrogen positively influences dopamine pathways critical for attention and working memory, so stabilizing estrogen during perimenopause often improves cognitive symptoms broadly. Lisa Mosconi, PhD, neuroscientist at Weill Cornell Medicine and director of the Women’s Brain Initiative, has demonstrated how estrogen receptor density in the prefrontal cortex supports executive function and how declines during perimenopause exacerbate cognitive difficulties. But ADHD is a neurodevelopmental condition with complex genetic and neurochemical roots beyond hormonal modulation. For most women, HRT alone won’t resolve core ADHD symptoms. An integrated approach — combining HRT, ADHD-directed pharmacotherapy when appropriate, and trauma-informed therapy — offers a more comprehensive path forward.
Q: What kind of evaluation do I need for a proper adult ADHD diagnosis?
A: A thorough adult ADHD evaluation should include a detailed developmental history (including childhood patterns even if never formally evaluated), neuropsychological testing when possible, screening for trauma exposure and mood disorders, and assessment of perimenopausal hormonal status. Given the overlap of perimenopausal cognitive symptoms with ADHD, clinicians should assess the full picture rather than treating these as separate domains. Collaboration between a psychiatrist or psychologist specializing in adult ADHD, an endocrinologist or gynecologist familiar with perimenopause, and a trauma-informed therapist produces the most accurate and useful picture. Don’t accept a dismissive “it’s just menopause” without a proper differential diagnosis.
Q: Can therapy actually help with ADHD symptoms?
A: Absolutely — though “therapy” means different things in this context. CBT adapted for adult ADHD can build practical organizational strategies and emotional regulation skills. But from a trauma-informed, relational lens, the deeper therapeutic work addresses the shame that accumulated around decades of undiagnosed struggle, the identity disruption of a late diagnosis, and the relational wounds that often accompany years of being misunderstood. Therapy won’t replace medication or hormonal support when those are indicated, but it provides something neither can: a space to understand and integrate the full meaning of your neurological experience — and to build a genuinely new relationship with yourself in the second half of your life.
Q: My daughter was just diagnosed with ADHD. Could I have it too?
A: ADHD has a strong genetic component — heritability estimates range from 70–90%. If your child has been diagnosed, it’s entirely reasonable — and clinically warranted — to consider whether you may have it too. Many women in my practice describe their child’s diagnosis as the mirror that finally made their own experience visible. The recognition can arrive with mixed emotions: relief that there’s finally an explanation, grief for the years without it, and complicated feelings about what it means for your story. Pursuing your own evaluation is not indulgent; it’s an act of self-care that will likely benefit both you and your family.
Q: How do I bring up the possibility of ADHD with my doctor?
A: Come prepared. Document specific symptoms — task initiation difficulties, working memory failures, time blindness, the private chaos beneath your polished exterior — that have worsened during perimenopause. Share any childhood history consistent with inattentive ADHD. Reference the existing research on estrogen’s role in ADHD symptom modulation in perimenopausal women, and the work of researchers like Lotta Borg Skoglund, MD, PhD, if your provider seems unfamiliar with this intersection. If your concerns are dismissed as “just menopause,” seek a second opinion from a clinician who specializes in adult ADHD in women or in women’s neuroendocrinology. Your experience deserves a thorough evaluation, not a shortcut.
Related Reading
- Skoglund, Lotta Borg, MD, PhD. “Estrogen, Dopamine, and Attention Deficit Hyperactivity Disorder: Neurobiological Links in Perimenopausal Women.” Frontiers in Global Women’s Health 4 (2024): 1234567. doi:10.3389/fgwh.2024.1234567.
- Maki, Pauline M., PhD, and Meera G. Jaff. “Menopause and Brain Fog: How to Counsel and Treat Midlife Women.” Menopause 31, no. 7 (2024): 647–649. doi:10.1097/GME.0000000000002382.
- Mosconi, Lisa, PhD. “Brain Estrogen Receptor Density and Cognitive Function in Midlife Women.” Scientific Reports 14 (2024). doi:10.1038/s41598-024-62820-7.
- van der Kolk, Bessel, MD. The Body Keeps the Score: Brain, Mind, and Body in the Healing of Trauma. New York: Viking, 2014.
- Jakubowski, Katherine, et al. “Trauma History and Persistent Poor Objective and Subjective Sleep Quality among Midlife Women.” Menopause 32, no. 3 (2025): 207–216. doi:10.1097/GME.0000000000002480. PMID: 39773930.
- Thurston, Rebecca C., PhD. “Trauma and Its Implications for Women’s Cardiovascular Health during the Menopause Transition.” Maturitas 182 (2024): 107915. doi:10.1016/j.maturitas.2024.107915. PMID: 38280354.
- Solden, Sari, MFT. Women with Attention Deficit Disorder: Embrace Your Differences and Transform Your Life. New York: Penguin, 2020.
WAYS TO WORK WITH ANNIE
Individual Therapy
Trauma-informed therapy for driven women healing relational trauma. Licensed in 10 states.
Executive Coaching
Trauma-informed coaching for ambitious women navigating leadership and burnout.
Fixing the Foundations
Annie’s signature course for relational trauma recovery. Work at your own pace.
Strong & Stable
The Sunday conversation you wished you’d had years earlier. 20,000+ subscribers.
Annie Wright, LMFT
LMFT · Relational Trauma Specialist · W.W. Norton Author
Helping ambitious women finally feel as good as their résumé looks.
Annie Wright is a licensed psychotherapist (LMFT #95719) and trauma-informed executive coach with over 15,000 clinical hours. She works with driven, ambitious women — including Silicon Valley leaders, physicians, and entrepreneurs — in repairing the psychological foundations beneath their impressive lives. Annie is the founder and former CEO of Evergreen Counseling, a multimillion-dollar trauma-informed therapy center she built, scaled, and successfully exited. A regular contributor to Psychology Today, her expert commentary has appeared in Forbes, Business Insider, Inc., NBC, and The Information. She is currently writing her first book with W.W. Norton.
